Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Morbidity in an adenosine deaminase-deficient patient during 27 years of enzyme replacement therapy.

Grunebaum E, Reid B, Naqvi A, Hershfield MS, Kim VH, Muller MP, Hicks LK, Lee E, Betschel S, Roifman CM.

Clin Immunol. 2019 Dec 5:108321. doi: 10.1016/j.clim.2019.108321. [Epub ahead of print]

PMID:
31812707
2.

Development and implementation of a quality improvement toolkit, iron deficiency in pregnancy with maternal iron optimization (IRON MOM): A before-and-after study.

Abdulrehman J, Lausman A, Tang GH, Nisenbaum R, Petrucci J, Pavenski K, Hicks LK, Sholzberg M.

PLoS Med. 2019 Aug 20;16(8):e1002867. doi: 10.1371/journal.pmed.1002867. eCollection 2019 Aug.

3.

Things We Do For No Reason: HIT Testing in Low Probability Patients.

Li A, Hicks LK, Fan E.

J Hosp Med. 2019 Jun 1;14(6):374-381. doi: 10.12788/jhm.3165. Epub 2019 Apr 8. No abstract available.

PMID:
30986184
4.

Treatment preferences of patients with relapsed and refractory multiple myeloma: a qualitative study.

Parsons JA, Greenspan NR, Baker NA, McKillop C, Hicks LK, Chan O.

BMC Cancer. 2019 Mar 25;19(1):264. doi: 10.1186/s12885-019-5467-x.

5.

Resolved HBV and anti-CD20 therapy.

Hicks LK, Feld JJ.

Blood. 2019 Jan 10;133(2):104-106. doi: 10.1182/blood-2018-11-882167. No abstract available.

PMID:
30630846
6.

Tackling overutilization of hospital tests and treatments: Lessons learned from a grassroots approach.

Hicks LK, O'Brien P, Sholzberg M, Veloce N, Trafford A, Sinclair D.

Healthc Manage Forum. 2018 Sep;31(5):186-190. doi: 10.1177/0840470418781172. Epub 2018 Aug 22.

PMID:
30133329
7.

The authors respond to "Is referral necessary for abnormal bleeding?"

Sholzberg M, Teitel J, Hicks LK.

CMAJ. 2017 Nov 6;189(44):E1369. doi: 10.1503/cmaj.733365. No abstract available.

8.

A 24-year-old woman with heavy menstrual bleeding.

Sholzberg M, Teitel J, Hicks LK.

CMAJ. 2017 Jun 5;189(22):E779-E780. doi: 10.1503/cmaj.161469. No abstract available.

9.

REDucing Unnecessary Coagulation Testing in the Emergency Department (REDUCED).

Fralick M, Hicks LK, Chaudhry H, Goldberg N, Ackery A, Nisenbaum R, Sholzberg M.

BMJ Qual Improv Rep. 2017 May 2;6(1). pii: u221651.w8161. doi: 10.1136/bmjquality.u221651.w8161. eCollection 2017.

10.

Rituximab in Lymphoma and Chronic Lymphocytic Leukaemia: A Practice Guideline.

Prica A, Baldassarre F, Hicks LK, Imrie K, Kouroukis T, Cheung M; Members of the Hematology Disease Site Group of the Cancer Care Ontario Program in Evidence-based Care.

Clin Oncol (R Coll Radiol). 2017 Jan;29(1):e13-e28. doi: 10.1016/j.clon.2016.09.004. Epub 2016 Oct 14.

PMID:
27746042
11.

Value Based Care and Patient-Centered Care: Divergent or Complementary?

Tseng EK, Hicks LK.

Curr Hematol Malig Rep. 2016 Aug;11(4):303-10. doi: 10.1007/s11899-016-0333-2. Review.

PMID:
27262855
12.

Identifying existing Choosing Wisely recommendations of high relevance and importance to hematology.

Hicks LK, Rajasekhar A, Bering H, Carson KR, Kleinerman J, Kukreti V, Ma A, Mueller BU, O'Brien SH, Panepinto JA, Pasquini MC, Sarode R, Wood WA.

Am J Hematol. 2016 Aug;91(8):787-92. doi: 10.1002/ajh.24412. Epub 2016 Jun 8.

13.

Cancer Mortality Among Recipients of Solid-Organ Transplantation in Ontario, Canada.

Acuna SA, Fernandes KA, Daly C, Hicks LK, Sutradhar R, Kim SJ, Baxter NN.

JAMA Oncol. 2016 Apr;2(4):463-9. doi: 10.1001/jamaoncol.2015.5137.

PMID:
26746479
14.

ASCO Provisional Clinical Opinion for Hepatitis B Virus Screening Before Cancer Therapy: Are These the Right Tests in the Right Patients?

Hicks LK, Lien K, Chan KK.

J Oncol Pract. 2015 Jul;11(4):e490-4. doi: 10.1200/JOP.2015.004945. No abstract available.

PMID:
26188049
15.

Hepatitis B virus screening before adjuvant chemotherapy in patients with early-stage breast cancer: a cost-effectiveness analysis.

Wong WW, Hicks LK, Tu HA, Pritchard KI, Krahn MD, Feld JJ, Chan KK.

Breast Cancer Res Treat. 2015 Jun;151(3):639-52. doi: 10.1007/s10549-015-3382-7. Epub 2015 May 12.

PMID:
25962692
16.

Poor recognition of risk factors for hepatitis B by physicians prescribing immunosuppressive therapy: a call for universal rather than risk-based screening.

Visram A, Chan KK, McGee P, Boro J, Hicks LK, Feld JJ.

PLoS One. 2015 Apr 15;10(4):e0120749. doi: 10.1371/journal.pone.0120749. eCollection 2015.

17.

Reframing overuse in health care: time to focus on the harms.

Hicks LK.

J Oncol Pract. 2015 May;11(3):168-70. doi: 10.1200/JOP.2015.004283. Epub 2015 Mar 24. No abstract available.

PMID:
25804988
18.

Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving rituximab for lymphoma: a meta-analysis.

Mozessohn L, Chan KK, Feld JJ, Hicks LK.

J Viral Hepat. 2015 Oct;22(10):842-9. doi: 10.1111/jvh.12402. Epub 2015 Mar 13. Review.

PMID:
25765930
19.

Five hematologic tests and treatments to question.

Hicks LK, Bering H, Carson KR, Haynes AE, Kleinerman J, Kukreti V, Ma A, Mueller BU, O'Brien SH, Panepinto JA, Pasquini MC, Rajasekhar A, Sarode R, Wood WA.

Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):599-603. doi: 10.1182/asheducation-2014.1.599. Epub 2014 Nov 18.

PMID:
25696917
20.

Prolonged clinical remissions in patients with relapsed or refractory follicular lymphoma treated with autologous stem cell transplantation incorporating rituximab.

Berinstein NL, Bhella S, Pennell NM, Cheung MC, Imrie KR, Spaner DE, Milliken V, Zhang L, Hewitt K, Boudreau A, Reis MD, Chesney A, Good D, Ghorab Z, Hicks LK, Piliotis E, Buckstein R.

Ann Hematol. 2015 May;94(5):813-23. doi: 10.1007/s00277-014-2288-5. Epub 2015 Jan 8.

PMID:
25567231
21.

Five hematologic tests and treatments to question.

Hicks LK, Bering H, Carson KR, Haynes AE, Kleinerman J, Kukreti V, Ma A, Mueller BU, O'Brien SH, Panepinto JA, Pasquini MC, Rajasekhar A, Sarode R, Wood WA.

Blood. 2014 Dec 4;124(24):3524-8. doi: 10.1182/blood-2014-09-599399.

PMID:
25472968
22.

The ASH Choosing Wisely®campaign: five hematologic tests and treatments to question.

Hicks LK, Bering H, Carson KR, Kleinerman J, Kukreti V, Ma A, Mueller BU, O'Brien SH, Pasquini M, Sarode R, Solberg L Jr, Haynes AE, Crowther MA.

Hematology Am Soc Hematol Educ Program. 2013;2013:9-14. doi: 10.1182/asheducation-2013.1.9.

PMID:
24319155
23.

The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question.

Hicks LK, Bering H, Carson KR, Kleinerman J, Kukreti V, Ma A, Mueller BU, O'Brien SH, Pasquini M, Sarode R, Solberg L Jr, Haynes AE, Crowther MA.

Blood. 2013 Dec 5;122(24):3879-83. doi: 10.1182/blood-2013-07-518423. Epub 2013 Dec 4.

PMID:
24307720
24.

Hepatitis B screening before chemotherapy: a survey of practitioners' knowledge, beliefs, and screening practices.

Lee RS, Bell CM, Singh JM, Hicks LK.

J Oncol Pract. 2012 Nov;8(6):325-8, 1 p following 328. doi: 10.1200/JOP.2012.000597. Epub 2012 Jul 31.

25.

Paying more than lip service to an oral lesion: a case of plasmablastic lymphoma.

Moayedi Y, Venos ES, Ghaffar H, Gough KA, Hicks LK.

BMJ Case Rep. 2012 Jul 13;2012. pii: bcr2012006452. doi: 10.1136/bcr-2012-006452.

26.

Unanswered Questions in HIV Hematology.

Leitch HA, Abramson JS, Cheung MC, Hicks LK.

Adv Hematol. 2012;2012:907025. doi: 10.1155/2012/907025. Epub 2012 Jun 4. No abstract available.

27.

Hepatitis B virus screening before chemotherapy for lymphoma: a cost-effectiveness analysis.

Zurawska U, Hicks LK, Woo G, Bell CM, Krahn M, Chan KK, Feld JJ.

J Clin Oncol. 2012 Sep 10;30(26):3167-73. doi: 10.1200/JCO.2011.40.7510. Epub 2012 Jun 18.

PMID:
22711851
28.

Incidence, predictors and significance of severe toxicity in patients with human immunodeficiency virus-associated Hodgkin lymphoma.

Ezzat HM, Cheung MC, Hicks LK, Boro J, Montaner JS, Lima VD, Harris M, Leitch HA.

Leuk Lymphoma. 2012 Dec;53(12):2390-6. doi: 10.3109/10428194.2012.697560. Epub 2012 Jun 18.

PMID:
22642935
29.

HIV-Associated Burkitt Lymphoma: Good Efficacy and Tolerance of Intensive Chemotherapy Including CODOX-M/IVAC with or without Rituximab in the HAART Era.

Rodrigo JA, Hicks LK, Cheung MC, Song KW, Ezzat H, Leger CS, Boro J, Montaner JS, Harris M, Leitch HA.

Adv Hematol. 2012;2012:735392. doi: 10.1155/2012/735392. Epub 2011 Nov 14.

30.
31.

Excessive neurotoxicity with ABVD when combined with protease inhibitor-based antiretroviral therapy in the treatment of AIDS-related Hodgkin lymphoma.

Cheung MC, Hicks LK, Leitch HA.

Clin Lymphoma Myeloma Leuk. 2010 Apr;10(2):E22-5. doi: 10.3816/CLML.2010.n.025.

PMID:
20371439
32.

Venous thromboembolism and nonsmall cell lung cancer: a pooled analysis of National Cancer Institute of Canada Clinical Trials Group trials.

Hicks LK, Cheung MC, Ding K, Hasan B, Seymour L, Le Maître A, Leighl NB, Shepherd FA.

Cancer. 2009 Dec 1;115(23):5516-25. doi: 10.1002/cncr.24596.

33.

Hemophagocytic lymphohistiocytosis-late diagnosis in an adult patient.

Ng D, Ghosh N, Hicks LK.

BMJ Case Rep. 2009;2009. pii: bcr05.2009.1858. doi: 10.1136/bcr.05.2009.1858. Epub 2009 Aug 17.

34.

Rituximab purging and maintenance combined with auto-SCT: long-term molecular remissions and prolonged hypogammaglobulinemia in relapsed follicular lymphoma.

Hicks LK, Woods A, Buckstein R, Mangel J, Pennell N, Zhang L, Imrie K, Spaner D, Cheung MC, Boudreau A, Reis M, Crump M, Berinstein NL.

Bone Marrow Transplant. 2009 May;43(9):701-8. doi: 10.1038/bmt.2008.382. Epub 2008 Nov 24.

PMID:
19029963
35.

A meta-analysis and systematic review of thalidomide for patients with previously untreated multiple myeloma.

Hicks LK, Haynes AE, Reece DE, Walker IR, Herst JA, Meyer RM, Imrie K; Hematology Disease Site Group of the Cancer Care Ontario Program in Evidence-based Care.

Cancer Treat Rev. 2008 Aug;34(5):442-52. doi: 10.1016/j.ctrv.2008.02.003. Epub 2008 Apr 1. Review.

PMID:
18381234
36.

Rituximab-induced serum sickness in a patient with follicular lymphoma.

Disperati P, Hicks LK, Buckstein R.

Leuk Lymphoma. 2007 Aug;48(8):1633-5. No abstract available.

PMID:
17701597
37.

A primer on data safety monitoring boards: mission, methods, and controversies.

Hicks LK, Laupacis A, Slutsky AS.

Intensive Care Med. 2007 Oct;33(10):1815-8. Epub 2007 Jul 28. Review. No abstract available.

PMID:
17661013
38.

Thrombocytosis.

Cheung MC, Hicks LK, Pendergrast J.

N Engl J Med. 2004 Jun 10;350(24):2524-5; author reply 2524-5. No abstract available.

PMID:
15190151
39.

Valproic acid overdose and haemodialysis.

Hicks LK, McFarlane PA.

Nephrol Dial Transplant. 2001 Jul;16(7):1483-6. Review. No abstract available.

PMID:
11427646
40.

Understanding the clinical dilemmas that shape medical students' ethical development: questionnaire survey and focus group study.

Hicks LK, Lin Y, Robertson DW, Robinson DL, Woodrow SI.

BMJ. 2001 Mar 24;322(7288):709-10. No abstract available.

41.

Mouse VH7183 recombination signal sequences mediate recombination more frequently than those of VHJ558.

Connor AM, Fanning LJ, Celler JW, Hicks LK, Ramsden DA, Wu GE.

J Immunol. 1995 Dec 1;155(11):5268-72.

PMID:
7594539
42.

Eating disorders and alcohol abuse in women.

Goldbloom DS, Naranjo CA, Bremner KE, Hicks LK.

Br J Addict. 1992 Jun;87(6):913-9.

PMID:
1525533
43.

Platelet serotonin uptake in bulimia nervosa.

Goldbloom DS, Hicks LK, Garfinkel PE.

Biol Psychiatry. 1990 Oct 1;28(7):644-7. No abstract available.

PMID:
2223931

Supplemental Content

Loading ...
Support Center